Russano, F.; Del Fiore, P.; Cassalia, F.; Benna, C.; Dall’Olmo, L.; Rastrelli, M.; Mocellin, S.
Do Tumor SURVIVIN and MDM2 Expression Levels Correlate with Treatment Response and Clinical Outcome in Isolated Limb Perfusion for In-Transit Cutaneous Melanoma Metastases? J. Pers. Med. 2023, 13, 1657.
https://doi.org/10.3390/jpm13121657
AMA Style
Russano F, Del Fiore P, Cassalia F, Benna C, Dall’Olmo L, Rastrelli M, Mocellin S.
Do Tumor SURVIVIN and MDM2 Expression Levels Correlate with Treatment Response and Clinical Outcome in Isolated Limb Perfusion for In-Transit Cutaneous Melanoma Metastases? Journal of Personalized Medicine. 2023; 13(12):1657.
https://doi.org/10.3390/jpm13121657
Chicago/Turabian Style
Russano, Francesco, Paolo Del Fiore, Fortunato Cassalia, Clara Benna, Luigi Dall’Olmo, Marco Rastrelli, and Simone Mocellin.
2023. "Do Tumor SURVIVIN and MDM2 Expression Levels Correlate with Treatment Response and Clinical Outcome in Isolated Limb Perfusion for In-Transit Cutaneous Melanoma Metastases?" Journal of Personalized Medicine 13, no. 12: 1657.
https://doi.org/10.3390/jpm13121657
APA Style
Russano, F., Del Fiore, P., Cassalia, F., Benna, C., Dall’Olmo, L., Rastrelli, M., & Mocellin, S.
(2023). Do Tumor SURVIVIN and MDM2 Expression Levels Correlate with Treatment Response and Clinical Outcome in Isolated Limb Perfusion for In-Transit Cutaneous Melanoma Metastases? Journal of Personalized Medicine, 13(12), 1657.
https://doi.org/10.3390/jpm13121657